AMETEK, Inc. (NYSE:AME - Free Report) - Analysts at Zacks Research reduced their Q3 2025 EPS estimates for AMETEK in a research report issued to clients and investors on Thursday, May 15th. Zacks Research analyst R. Department now anticipates that the technology company will post earnings per share of $1.78 for the quarter, down from their prior forecast of $1.79. The consensus estimate for AMETEK's current full-year earnings is $7.15 per share. Zacks Research also issued estimates for AMETEK's Q2 2026 earnings at $1.84 EPS and Q3 2026 earnings at $1.89 EPS.
AMETEK (NYSE:AME - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The technology company reported $1.75 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.69 by $0.06. AMETEK had a return on equity of 16.94% and a net margin of 19.83%. The firm had revenue of $1.73 billion for the quarter, compared to analysts' expectations of $1.74 billion. During the same period last year, the firm earned $1.64 earnings per share. The company's revenue for the quarter was down .2% compared to the same quarter last year.
Other equities research analysts have also recently issued research reports about the stock. StockNews.com raised shares of AMETEK from a "hold" rating to a "buy" rating in a research report on Monday, May 12th. Morgan Stanley started coverage on AMETEK in a research note on Monday, April 14th. They issued an "equal weight" rating and a $170.00 target price on the stock. Robert W. Baird dropped their price objective on AMETEK from $197.00 to $190.00 and set a "neutral" rating for the company in a report on Wednesday, May 7th. Royal Bank of Canada boosted their target price on AMETEK from $194.00 to $201.00 and gave the company an "outperform" rating in a research note on Friday, May 2nd. Finally, Truist Financial lifted their price target on shares of AMETEK from $196.00 to $200.00 and gave the company a "buy" rating in a report on Monday, May 5th. One research analyst has rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $198.10.
Read Our Latest Stock Analysis on AME
AMETEK Trading Down 1.7%
Shares of NYSE:AME traded down $3.13 during trading on Monday, reaching $177.67. 1,270,590 shares of the company traded hands, compared to its average volume of 1,293,399. The company has a current ratio of 1.24, a quick ratio of 0.75 and a debt-to-equity ratio of 0.15. AMETEK has a 52-week low of $145.02 and a 52-week high of $198.33. The firm has a market capitalization of $41.02 billion, a price-to-earnings ratio of 29.96, a P/E/G ratio of 2.73 and a beta of 1.12. The business's fifty day moving average is $168.57 and its 200-day moving average is $179.93.
AMETEK announced that its board has approved a share buyback program on Friday, February 7th that allows the company to repurchase $1.25 billion in shares. This repurchase authorization allows the technology company to buy up to 2.9% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's management believes its shares are undervalued.
AMETEK Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Friday, June 13th will be given a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a dividend yield of 0.70%. The ex-dividend date is Friday, June 13th. AMETEK's dividend payout ratio is presently 20.29%.
Insider Buying and Selling
In other news, Director Thomas A. Amato sold 710 shares of the stock in a transaction on Thursday, March 27th. The stock was sold at an average price of $176.64, for a total value of $125,414.40. Following the sale, the director now directly owns 10,560 shares of the company's stock, valued at approximately $1,865,318.40. This represents a 6.30% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Steven W. Kohlhagen sold 1,320 shares of the firm's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $189.41, for a total value of $250,021.20. Following the transaction, the director now owns 22,029 shares of the company's stock, valued at $4,172,512.89. The trade was a 5.65% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.57% of the stock is owned by company insiders.
Institutional Trading of AMETEK
Several institutional investors have recently bought and sold shares of the company. Norges Bank purchased a new position in AMETEK in the fourth quarter worth about $697,080,000. Capital World Investors increased its position in shares of AMETEK by 70.0% during the fourth quarter. Capital World Investors now owns 5,760,017 shares of the technology company's stock valued at $1,038,301,000 after acquiring an additional 2,371,062 shares in the last quarter. Invesco Ltd. raised its holdings in AMETEK by 127.2% in the 1st quarter. Invesco Ltd. now owns 3,479,397 shares of the technology company's stock worth $598,943,000 after acquiring an additional 1,947,831 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in AMETEK by 21.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 10,970,047 shares of the technology company's stock valued at $1,888,385,000 after acquiring an additional 1,908,742 shares in the last quarter. Finally, Lazard Asset Management LLC boosted its stake in AMETEK by 393.1% during the 4th quarter. Lazard Asset Management LLC now owns 1,215,087 shares of the technology company's stock valued at $219,030,000 after purchasing an additional 968,661 shares during the last quarter. 87.43% of the stock is owned by hedge funds and other institutional investors.
About AMETEK
(
Get Free Report)
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Featured Articles

Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report